GOLDMAN SACHS GROUP INC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$80,989
-34.2%
111,601
-11.8%
0.00%
Q3 2022$123,000
-69.2%
126,570
-39.4%
0.00%
Q2 2022$399,000
-50.3%
208,920
+29.3%
0.00%
Q1 2022$803,000
-5.2%
161,567
+44.1%
0.00%
Q4 2021$847,000
+22.8%
112,100
+28.3%
0.00%
Q3 2021$690,000
-77.7%
87,398
-60.8%
0.00%
-100.0%
Q2 2021$3,094,000
+234.5%
223,039
+404.6%
0.00%
Q1 2021$925,000
+71.9%
44,203
+36.4%
0.00%
Q4 2020$538,000
-3.9%
32,418
-1.7%
0.00%
Q3 2020$560,000
-39.4%
32,983
-40.7%
0.00%
Q2 2020$924,000
+463.4%
55,630
+403.2%
0.00%
Q4 2019$164,000
-44.0%
11,055
-48.5%
0.00%
Q3 2019$293,000
+5.4%
21,450
-26.9%
0.00%
Q1 2019$278,00029,3560.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 315,668$1,272,1421.63%
MPM ASSET MANAGEMENT LLC 313,136$1,261,9380.68%
View complete list of HARPOON THERAPEUTICS INC shareholders